SF
GMAB icon

Synovus Financial’s Genmab GMAB Stock Holding History

Synovus Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.07M Buy
34,883
+85
+0.2% +$2.07K 0.01% 504
2025
Q2 		$719K Buy
34,798
+2,457
+8% +$50.4K 0.01% 573
2025
Q1 		$633K Buy
+32,341
New +$678K 0.01% 601
2024
Q2 		– Sell
-82,858
Closed -$2.48M – 857
2024
Q1 		$2.48M Buy
82,858
+3,877
+5% +$114K 0.03% 302
2023
Q4 		$2.51M Buy
78,981
+326
+0.4% +$10.2K 0.04% 293
2023
Q3 		$2.77M Buy
78,655
+2,449
+3% +$93.3K 0.03% 287
2023
Q2 		$2.9M Sell
76,206
-4,540
-6% -$181K 0.03% 282
2023
Q1 		$3.05M Sell
80,746
-13,827
-15% -$531K 0.03% 265
2022
Q4 		$4.01M Buy
94,573
+997
+1% +$41.1K 0.05% 215
2022
Q3 		$3.01M Sell
93,576
-573
-0.6% -$20.1K 0.04% 247
2022
Q2 		$3.06M Buy
94,149
+986
+1% +$31.9K 0.04% 238
2022
Q1 		$3.37M Buy
93,163
+8,436
+10% +$290K 0.04% 244
2021
Q4 		$3.35M Buy
84,727
+5,113
+6% +$213K 0.03% 250
2021
Q3 		$3.48M Sell
79,614
-36,244
-31% -$1.63M 0.04% 228
2021
Q2 		$4.72M Buy
115,858
+1,413
+1% +$54.5K 0.05% 187
2021
Q1 		$3.76M Buy
114,445
+18,303
+19% +$688K 0.04% 199
2020
Q4 		$3.91M Buy
96,142
+4,679
+5% +$175K 0.05% 197
2020
Q3 		$3.35M Sell
91,463
-3,469
-4% -$125K 0.04% 194
2020
Q2 		$3.22M Sell
94,932
-4,032
-4% -$110K 0.05% 179
2020
Q1 		$2.1M Buy
98,964
+2,743
+3% +$61.1K 0.03% 255
2019
Q4 		$2.15M Sell
96,221
-45,696
-32% -$997K 0.03% 234
2019
Q3 		$2.88M Buy
+141,917
New +$2.8M 0.04% 186

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Synovus Financial's GMAB Position: Q3 2025 in Review

Synovus Financial increased its Genmab (GMAB) stake by 0.24% in Q3 2025, buying an estimated $2.07K and bringing the position to 34,883 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #504.

Synovus Financial first reported a position in GMAB in Q3 2019 and has held it in 22 quarters since. The position peaked at $4.72M in Q2 2021. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Synovus Financial held 34,883 shares of Genmab worth $1.07M as of Q3 2025.
  • Synovus Financial bought 85 Genmab shares in Q3 2025, an estimated $2.07K.
  • Genmab made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #504 holding.
  • Synovus Financial first reported a position in Genmab in Q3 2019 and has held it in 22 quarters since.
  • Synovus Financial's Genmab position peaked at $4.72M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.